Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives

por Mina, Roberto, Oliva, Stefania, Boccadoro, Mario
Publicado 2020

Erratum: Mina, R.; et al. Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives. J. Clin. Med. 2020, 9, 2142

por Mina, Roberto, Oliva, Stefania, Boccadoro, Mario
Publicado 2020

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma

por Bonello, Francesca, Mina, Roberto, Boccadoro, Mario, Gay, Francesca
Publicado 2019

Emerging drugs and combinations to treat multiple myeloma

por Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
Publicado 2017

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors

por Boccalatte, Francesco, Mina, Roberto, Aroldi, Andrea, Leone, Sarah, Suryadevara, Carter M., Placantonakis, Dimitris G., Bruno, Benedetto
Publicado 2022

Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center

por Tore, Davide, Rampado, Osvaldo, Guarnaccia, Carla, Mina, Roberto, Oronzio, Maria, Santonocito, Ambra, Serafini, Alessandro, Strazzarino, Giulio Antonino, Gianusso, Laura, Bringhen, Sara, Fonio, Paolo, Depaoli, Alessandro
Publicado 2021

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma

por Bonello, Francesca, Rocchi, Serena, Barilà, Gregorio, Sandrone, Michela, Talarico, Marco, Zamagni, Elena, Scaldaferri, Matilde, Vedovato, Susanna, Bertiond, Cecilia, Pavan, Laura, Bringhen, Sara, Cattel, Francesco, Zambello, Renato, Cavo, Michele, Mina, Roberto
Publicado 2022

Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study

por Kaufman, Jonathan L., Mina, Roberto, Jakubowiak, Andrzej J., Zimmerman, Todd L., Wolf, Jeffrey J., Lewis, Colleen, Gleason, Charise, Sharp, Cathy, Martin, Thomas, Heffner, Leonard T., Nooka, Ajay K., Harvey, R. Donald, Lonial, Sagar
Publicado 2019

P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL

por Montefusco, Vittorio, Maria Cafro, Anna, Margiotta-Casaluci, Gloria, Patriarca, Francesca, Mina, Roberto, D’agostino5, Mattia, Palma, Anna Benedetta Dalla, Rizzi, Rita, Genua, Angelo, Fazio, Francesca, Paris, Laura, Belotti, Angelo, Rizzello, Ilaria, Conticello, Concetta, Carlo-Stella, Carmelo, Boccadoro, Mario
Publicado 2023

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies

por Bringhen, Sara, Mina, Roberto, Petrucci, Maria Teresa, Gaidano, Gianluca, Ballanti, Stelvio, Musto, Pellegrino, Offidani, Massimo, Spada, Stefano, Benevolo, Giulia, Ponticelli, Elena, Galieni, Piero, Cavo, Michele, Di Toritto, Tommaso Caravita, Di Raimondo, Francesco, Montefusco, Vittorio, Palumbo, Antonio, Boccadoro, Mario, Larocca, Alessandra
Publicado 2019

P872: EFFICACY OF DARATUMUMAB PLUS BORTEZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA PRESENTING WITH EXTRAMEDULLARY DISEASE: A EUROPEAN MYELOMA NETWO...

por Beksac, Meral, Tuglular, Tulin, Gay, Francesca, Mina, Roberto, Katodritou, Eirini, Unal, Ali, Cavo, Michele, Hayri Ozsan, Guner, van der Velden, Vincent H.J., Beverloo, Berna, Vermeulen, Michael, van Duin, Mark, Cengiz, Guldane, Gokmen Sevindik, Omur, Merante, Serena, Manousou, Kyriaki, Sonneveld, Pieter, Terpos, Evangelos
Publicado 2023

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies

por Mina, Roberto, Bonello, Francesca, Petrucci, Maria Teresa, Liberati, Anna Marina, Conticello, Concetta, Ballanti, Stelvio, Musto, Pellegrino, Olivieri, Attilio, Benevolo, Giulia, Capra, Andrea, Gilestro, Milena, Galieni, Piero, Cavo, Michele, Siniscalchi, Agostina, Palumbo, Antonio, Montefusco, Vittorio, Gaidano, Gianluca, Omedé, Paola, Boccadoro, Mario, Bringhen, Sara
Publicado 2020

P804: PLASMA CELL LEUKEMIA-LIKE TRANSCRIPTOME OF BONE MARROW PLASMA CELLS AND CIRCULATING TUMOR CELL LEVELS IN PERIPHERAL BLOOD COMPLEMENTARILY DEFINE HIGH-RISK IN NEWLY DIAGNOSED...

por D’agostino, Mattia, Bruinink, Davine Hofste Op, van Duin, Mark, Rota-Scalabrini, Delia, Bertamini, Luca, Kuiper, Rowan, Belotti, Angelo, Marasco, Vincenzo, Oliva, Stefania, Rivolti, Elena, Rogers, Jennifer, Mina, Roberto, Grasso, Mariella, Ledda, Antonio, Offidani, Massimo, Galli, Monica, Cavo, Michele, Broijl, Annemiek, Musto, Pellegrino, Bruno, Benedetto, Boccadoro, Mario, Sonneveld, Pieter, Gay, Francesca
Publicado 2023

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

por Mina, Roberto, Joseph, Nisha S., Gay, Francesca, Kastritis, Efstathios, Petrucci, Maria Teresa, Kaufman, Jonathan L., Montefusco, Vittorio, Gavriatopoulou, Maria, Patriarca, Francesca, Omedé, Paola, Boise, Lawrence H., Roussou, Maria, Giuliani, Nicola, Oliva, Stefania, Offidani, Massimo, Belotti, Angelo, Jaye, David L., De Paoli, Lorenzo, Terpos, Evangelos, Lonial, Sagar, Boccadoro, Mario, Nooka, Ajay K., Dimopoulos, Meletios A.
Publicado 2020

Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing

por Oliva, Stefania, Genuardi, Elisa, Paris, Laura, D'Agostino, Mattia, Rogers, Jennifer, Rota-Scalabrini, Delia, Jacob, Allison P., Patriarca, Francesca, Luppi, Mario, Bertazzoni, Paola, Velluti, Cristina, Capra, Andrea, Saraci, Elona, Rossi, Marco, Allegra, Alessandro, Mina, Roberto, Gentile, Massimo, Kirsch, Ilan R., Belotti, Angelo, Cavo, Michele, Bruno, Benedetto, Musto, Pellegrino, Boccadoro, Mario, Zamagni, Elena, Gay, Francesca
Publicado 2023

Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis

por Mangiacavalli, Silvia, Cartia, Claudio Salvatore, Galli, Monica, Pezzatti, Sara, Belotti, Angelo, Fazio, Francesca, Mina, Roberto, Marcatti, Magda, Cafro, Anna, Zambello, Renato, Paris, Laura, Barilà, Gregorio, Olivares, Cecilia, Pompa, Alessandra, Mazza, Rita, Farina, Francesca, Soldarini, Martina, Benvenuti, Pietro, Pagani, Giuseppina, Palumbo, Michele, Masoni, Valeria, Ferretti, Virginia Valeria, Klersy, Catherine, Arcaini1, Luca, Petrucci, Maria Teresa
Publicado 2022

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled...

por Larocca, Alessandra, Mina, Roberto, Offidani, Massimo, Liberati, Anna Marina, Ledda, Antonio, Patriarca, Francesca, Evangelista, Andrea, Spada, Stefano, Benevolo, Giulia, Oddolo, Daniela, Innao, Vanessa, Cangiolosi, Clotilde, Bernardini, Annalisa, Musto, Pellegrino, Amico, Valeria, Fraticelli, Vincenzo, Paris, Laura, Giuliani, Nicola, Falcone, Antonietta Pia, Zambello, Renato, De Paoli, Lorenzo, Romano, Alessandra, Palumbo, Antonio, Montefusco, Vittorio, Hájek, Roman, Boccadoro, Mario, Bringhen, Sara
Publicado 2020

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase...

por Mina, Roberto, Belotti, Angelo, Petrucci, Maria Teresa, Zambello, Renato, Capra, Andrea, Di Lullo, Giacomo, Ronconi, Sonia, Pescosta, Norbert, Grasso, Mariella, Monaco, Federico, Cellini, Claudia, Gobbi, Marco, Ballanti, Stelvio, de Fabritiis, Paolo, Mosca-Siez, Maria Letizia, Marchetti, Monia, Liberati, Anna Marina, Offidani, Massimo, Giuliani, Nicola, Ria, Roberto, Musto, Pellegrino, Romano, Alessandra, Sonneveld, Pieter, Boccadoro, Mario, Larocca, Alessandra
Publicado 2020

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial

por Mina, Roberto, Falcone, Antonietta Pia, Bringhen, Sara, Liberati, Anna Marina, Pescosta, Norbert, Petrucci, Maria Teresa, Ciccone, Giovannino, Capra, Andrea, Patriarca, Francesca, Rota-Scalabrini, Delia, Bonello, Francesca, Musolino, Caterina, Cea, Michele, Zambello, Renato, Tacchetti, Paola, Belotti, Angelo, Cellini, Claudia, Paris, Laura, Grasso, Mariella, Aquino, Sara, De Paoli, Lorenzo, De Sabbata, Giovanni, Ballanti, Stelvio, Offidani, Massimo, Boccadoro, Mario, Monaco, Federico, Corradini, Paolo, Larocca, Alessandra
Publicado 2021

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies

por Passamonti, Francesco, Romano, Alessandra, Salvini, Marco, Merli, Francesco, Porta, Matteo G. Della, Bruna, Riccardo, Coviello, Elisa, Romano, Ilaria, Cairoli, Roberto, Lemoli, Roberto, Farina, Francesca, Venditti, Adriano, Busca, Alessandro, Ladetto, Marco, Massaia, Massimo, Pinto, Antonio, Arcaini, Luca, Tafuri, Agostino, Marchesi, Francesco, Fracchiolla, Nicola, Bocchia, Monica, Armiento, Daniele, Candoni, Anna, Krampera, Mauro, Luppi, Mario, Cardinali, Valeria, Galimberti, Sara, Cattaneo, Chiara, La Barbera, Elettra Ortu, Mina, Roberto, Lanza, Francesco, Visani, Giuseppe, Musto, Pellegrino, Petrucci, Luigi, Zaja, Francesco, Grossi, Paolo A., Bertù, Lorenza, Pagano, Livio, Corradini, Paolo
Publicado 2021